Detection of EBV genomes in plasmablasts/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH
被引:31
作者:
Calattini, Sara
论文数: 0引用数: 0
h-index: 0
机构:
NIAID, Med Virol Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USANIAID, Med Virol Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
Calattini, Sara
[1
]
Sereti, Irini
论文数: 0引用数: 0
h-index: 0
机构:
NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USANIAID, Med Virol Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
Sereti, Irini
[2
]
Scheinberg, Philip
论文数: 0引用数: 0
h-index: 0
机构:
NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USANIAID, Med Virol Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
Scheinberg, Philip
[3
]
Kimura, Hiroshi
论文数: 0引用数: 0
h-index: 0
机构:
Nagoya Univ, Dept Virol, Grad Sch Med, Nagoya, Aichi 4648601, JapanNIAID, Med Virol Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
Kimura, Hiroshi
[4
]
Childs, Richard W.
论文数: 0引用数: 0
h-index: 0
机构:
NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USANIAID, Med Virol Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
Childs, Richard W.
[3
]
Cohen, Jeffrey I.
论文数: 0引用数: 0
h-index: 0
机构:
NIAID, Med Virol Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USANIAID, Med Virol Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
Cohen, Jeffrey I.
[1
]
机构:
[1] NIAID, Med Virol Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA
[3] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
[4] Nagoya Univ, Dept Virol, Grad Sch Med, Nagoya, Aichi 4648601, Japan
EPSTEIN-BARR-VIRUS;
IN-SITU HYBRIDIZATION;
ORGAN TRANSPLANT RECIPIENTS;
HUMAN PLASMA-CELLS;
PERIPHERAL-BLOOD;
HUMAN THYMOCYTES;
INFECTION;
LYMPHOCYTES;
EXPRESSION;
RECEPTOR;
D O I:
10.1182/blood-2010-05-285452
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Epstein-Barr virus (EBV) is present in B cells in the blood of healthy people; few studies have looked for EBV in other cell types in blood from patients with lymphoproliferative disorders. We use a new technique combining immunofluorescent cell-surface staining and fluorescent in situ hybridization to quantify both EBV copy number per cell and cell types in blood from patients with high EBV DNA loads. In addition to CD20(+) B cells, EBV was present in plasmablast/plasma cells in the blood of 50% of patients, in monocytes or T cells in a small proportion of patients, and in "non-B, non-T, non-monocytes" in 69% of patients. The mean EBV copy number in B cells was significantly higher than in plasmablast/plasma cells. There was no correlation between EBV load and virus copy number per cell. Although we detected CD21, the EBV B-cell receptor, on EBV-infected B cells, we could not detect it on virus-infected T cells. These findings expand the range of cell types infected in the blood. Determining the number of EBV genomes per cell and the type of cells infected in patients with high EBV loads may provide additional prognostic information for the development of EBV lymphoproliferative diseases. (Blood. 2010; 116(22): 4546-4559)